Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Kathleen Sebelius

Director at Humacyte, Inc. (HUMA)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-36.5%
vs. S&P 500-40.3%
Beat the market0%
Paper profit on buys−$27K
Total bought / sold$50K / $0

Reported trades

Filed Stock Type Shares Price Value Since
May 20SEC HUMAHumacyte, Inc. Buy 56,818148,025 held (+62%) $0.88 $50K -54.0%
  • Buy

    Director Kathleen Sebelius bought $50K of HUMA at $0.88 — first open-market purchase in our records; raises the stake by 62%.